Navigation Links
Global Gastrointestinal Drugs Market to Reach US$61.1 bn by 2024: Rising Demand for Acid Neutralizers to Reflect Positively on Market's Growth, Observes TMR
Date:3/6/2017

ALBANY, New York, March 6, 2017 /PRNewswire/ --

The global gastrointestinal drugs market demonstrates a consolidated landscape with top three players, namely, Takeda Pharmaceutical, Valeant Pharmaceuticals Inc., and Janssen Biotech Inc., holding the market with majority share, finds a report by Transparency Market Research (TMR). These three players, collectively, accounted for a share of 61% in 2016. The market is moderately competitive as of now; however, the degree of competition within this market is likely to increase remarkably over the next few years, reports the study.

As per the research report, the global market for gastrointestinal drugs presented an opportunity worth US$45.5 bn in 2015. Analysts estimate it to swell at a CAGR of 4.90% during the period from 2016 to 2024 and increase to US$61.1 bn by the end of the forecast period. Acid neutralizers have been registering a higher demand from consumers and are projected to remain doing so over the forthcoming years, thanks to the growing prevalence of gastroesophageal reflux disease (GERD) across the world.

Browse Market Research Report @ http://www.transparencymarketresearch.com/gastrointestinal-drugs-market.html

North America to Derive Growth from Increasing Geriatric Population 

Latin America, North America, Europe, Asia Pacific, and the Middle East and Africa are the key regional markets for gastrointestinal drugs across the world. In this research report, a comparative analysis of these markets has been carried out in order to identify the leading and the most lucrative among these. According to this study, North America led the global market in 2016 with a share of 41%, thanks to the presence of favorable reimbursement policies concerning the treatment of gastrointestinal diseases. With the significant increase in the number of elderly people, who are prone to gastrointestinal disorders, the North America market for gastrointestinal drugs is likely to maintain its lead over the forthcoming years.

Europe, which also reported impressive growth over the past few years, is likely to witness continued progress during the forecast period. The introduction of biosimilar for the treatment of inflammatory bowel diseases by various patent-protected brands is projected to boost the market for gastrointestinal drugs in Europe over the next few years.

Among others, Asia Pacific is likely to provide the most lucrative opportunities to for the growth of the gastrointestinal drugs market in the years to come. The infrastructural improvements in the medical and healthcare industry, significant increase in the investments and funding in life sciences research, and the technological advancements in the therapies for the treatment of gastrointestinal diseases in emerging countries, such as India and China, are anticipated to drive the gastrointestinal drugs market in Asia Pacific in the near future, states the research study.

Fill the form for an exclusive sample of this report @ http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=20987

Increasing Prevalence of Gastrointestinal Diseases to Boost Demand for Gastrointestinal Drugs 

"The global market for gastrointestinal drugs derives much of its growth from the increasing prevalence of gastrointestinal diseases across the world," says an analyst at TMR. According to a report by the World Gastroenterology Organization, the gastro-esophageal reflux disease (GERD), is having a worldwide prevalence of approximately 15% to 25% with a high pace of incidence. This, consequently, is reflecting greatly on the demand for gastrointestinal drugs greatly. Along with this, the augmenting level of awareness about the availability of the treatments and the rise in investments to increase research activities for the development of these drugs are also driving this market substantially.

On the other hand, the unknown etiology of IBD and IBS and the dearth of a permanent cure for gastrointestinal drugs may restrict the growth of this market in the years to come. However, the continual technological advancements in the treatment therapies are expected to impact positively on this market in the long terms, notes the study.

Browse Press Release: http://www.transparencymarketresearch.com/pressrelease/gastrointestinal-drugs-market.htm

The study presented here is based on a report by Transparency Market Research (TMR) titled "Gastrointestinal Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024."

The global gastrointestinal drugs market is segmented as follows:

By Drug Class 

  • Acid Neutralizers
    • Antacids
    • H2 antagonists
    • Proton pump inhibitors
  • Antidiarrheal and Laxatives
  • Antiemetic and Antinauseants
  • Anti-inflammatory drugs
  • Biologics
  • Others (Antispasmodic etc.)

By Route of Administration 

  • Oral
  • Parenteral
  • Rectal

By Disorder Type 

  • Gastro Esophageal Reflux Disease
  • Inflammatory Bowel Disease
  • Irritable Bowel Syndrome

By Distribution Channel 

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region 

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
    • Southern Global
  • Middle East & Africa
    • GCC countries
    • South Africa
    • Rest of Middle East & Africa

Browse Related Research Report: 

Hospital Acquired Infection Treatment Market (Infection Type - Urinary Tract Infections, Ventilator Associated Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infection, ENT Infections, Skin Infection, and Bone Infection; Treatment Type - Antibacterial, Antiviral, Antifungal Treatment, Antiparasitic, Antiprotozoal, and Anti-TB Treatment; Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Drug Store, and E-Commerce) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

http://www.transparencymarketresearch.com/hospital-acquired-infection-treatment-market.html

Electrosurgical Devices Market (Product Type - Radiofrequency Electrosurgery Devices (Monopolar and Bipolar), Electrocautery Devices (Monopolar and Bipolar), and Electrosurgical Accessories; Application - General Surgery, Gynecology, Cardiology, Urology, Dermatology and Cosmetology, Orthopedics, Neurology, Oncology, Dentistry, and Gastrointestinal Surgery; End User - Hospitals, Ambulatory Surgery Centers, and Specialized Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

http://www.transparencymarketresearch.com/electrosurgical-devices-market.html

Bunsen Burners Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

http://www.transparencymarketresearch.com/bunsen-burners-market.html

About Us: 

Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR's global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact Us:
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com
Blog: http://www.tmrblog.com/


'/>"/>
SOURCE Transparency Market Research
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Global Information Online Market Research Portal Provides Complimentary Sample Service for Customers to Preview Reports by Global Industry Analysts
2. Cumberland Pharmaceuticals To Present At The UBS Global Healthcare Conference In New York
3. The Rockley Group and Content Rules Ink Deal to Extend Global Reach
4. AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference
5. Amgen To Present At The UBS Global Life Sciences Conference
6. HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast
7. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City
8. PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems
9. Orexigen Therapeutics to Present at the UBS Global Healthcare Conference
10. TRACE Releases 2012 Global Enforcement Report
11. Valeant Pharmaceuticals To Present At 34th Annual Goldman Sachs Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... --  West Pharmaceutical Services, Inc. (NYSE: WST), a ... today shared the results of a study highlighting the ... administration of polio vaccines. The study results were presented ... by Dr. Ondrej Mach , Clinical Trials and ... and recently published in the journal Vaccine. i ...
(Date:10/4/2017)... , Oct. 4, 2017  South Korean-based healthcare ... CPR training aide "cprCUBE" on Kickstarter. The device will ... during cardiac arrests with better efficiency compared to the ... offers real-time feedback on efficacy of the compression for ... campaign has a goal to raise $5,000. ...
(Date:10/2/2017)... Mich. , Oct. 2, 2017 Diplomat ... 8th Day Software and Consulting, LLC , and ... 8th Day Software, based in Tennessee ... LLC. 8th Day expands EnvoyHealth,s service offerings for health ... development. "In an ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 2017 , ... “The Journey: From the Mountains to the Mission Field”: the ... in the Philippines. “The Journey: From the Mountains to the Mission Field” is the ... She has taught all ages and currently teaches a class of ladies at her ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... for healthcare compliance program management, will showcase a range of technology and learning ... Assisted Living (NCAL) Convention and Expo to be held October 14–18, 2017 at ...
(Date:10/12/2017)... , ... October 12, 2017 , ... Planet Fitness, one ... U.S., announced today its plans to open a flagship location in Covington, LA at ... former Rooms To Go store next to Office Depot in the Holiday Square shopping ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), ... of an innovative new design of the shoulder pad. The shoulder pad provides ... while controlling your pain while using cold therapy. By utilizing ice and water that ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, ... post-acute health care, have expanded their existing home health joint venture through an ... has been operating a joint venture home health company with Asante, delivering clinically ...
Breaking Medicine News(10 mins):